LS Investment Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,912
| Closed | -$205K | – | 911 |
|
|
2020
Q3 | $205K | Hold |
3,912
| – | – | 0.01% | 709 |
|
|
2020
Q2 | $130K | Buy |
3,912
+673
| +21% | +$21.4K | 0.01% | 898 |
|
|
2020
Q1 | $88K | Hold |
3,239
| – | – | 0.01% | 940 |
|
|
2019
Q4 | $64K | Hold |
3,239
| – | – | ﹤0.01% | 1257 |
|
|
2019
Q3 | $42K | Hold |
3,239
| – | – | ﹤0.01% | 1346 |
|
|
2019
Q2 | $40K | Hold |
3,239
| – | – | ﹤0.01% | 1368 |
|
|
2019
Q1 | $47K | Hold |
3,239
| – | – | ﹤0.01% | 1319 |
|
|
2018
Q4 | $36K | Sell |
3,239
-4,850
| -60% | -$67.5K | ﹤0.01% | 1360 |
|
|
2018
Q3 | $213K | Sell |
8,089
-898
| -10% | -$24.3K | 0.01% | 810 |
|
|
2018
Q2 | $184K | Sell |
8,987
-67
| -0.7% | -$1.44K | 0.01% | 910 |
|
|
2018
Q1 | $164K | Sell |
9,054
-246
| -3% | -$4.1K | 0.01% | 944 |
|
|
2017
Q4 | $130K | Buy |
9,300
+3,479
| +60% | +$47K | 0.01% | 1071 |
|
|
2017
Q3 | $108K | Buy |
5,821
+1,118
| +24% | +$18.7K | 0.01% | 1135 |
|
|
2017
Q2 | $79K | Hold |
4,703
| – | – | ﹤0.01% | 1209 |
|
|
2017
Q1 | $63K | Buy |
4,703
+2,055
| +78% | +$32.2K | ﹤0.01% | 1267 |
|
|
2016
Q4 | $40K | Hold |
2,648
| – | – | ﹤0.01% | 1342 |
|
|
2016
Q3 | $31K | Hold |
2,648
| – | – | ﹤0.01% | 1397 |
|
|
2016
Q2 | $29K | Buy |
2,648
+360
| +16% | +$3.71K | ﹤0.01% | 1400 |
|
|
2016
Q1 | $21K | Hold |
2,288
| – | – | ﹤0.01% | 1463 |
|
|
2015
Q4 | $34K | Hold |
2,288
| – | – | ﹤0.01% | 1305 |
|
|
2015
Q3 | $38K | Buy |
2,288
+132
| +6% | +$2.7K | ﹤0.01% | 1262 |
|
|
2015
Q2 | $49K | Buy |
+2,156
| New | +$42.9K | ﹤0.01% | 1182 |
|
LS Investment Advisors's MNTA Position: Q4 2020 in Review
LS Investment Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 3,912 shares — an estimated $205K sold.
LS Investment Advisors first reported a position in MNTA in Q2 2015 and held it in 22 quarters. The position peaked at $213K in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- LS Investment Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- LS Investment Advisors sold 3,912 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $205K.
- LS Investment Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2015 and held it in 22 quarters.
- LS Investment Advisors's Momenta Pharmaceuticals, Inc. position peaked at $213K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on LS Investment Advisors's 13F filing for Q4 2020, filed 10 Feb 2021.